Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
THOR: Herceptin Continuation Beyond Progression in HER2+ Metastatic Breast Cancer
NCT00448279Phase 3Completed
- Sponsor
- Roche
- Start
- Apr 2007
- Primary completion
- Sep 2010
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of trastuzumab in breast cancer, sponsored by Roche. Started Apr 2007; status: completed.
02
Drugs
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00448279.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00448279.